Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7306 p3
3 July 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Charter links (more)


Judge makes decision on costs in SOS court case

High Court case: costs awarded to defendants on standard basis

The final decision on how costs are to be awarded against the Save Our Society claimants in the Charter court case was announced this week.

Mr Justice Park had already said that costs would be awarded against the SOS litigants following the summary dismissal of the SOS High Court action against the Royal Pharmaceutical Society and 16 members of its Council. At the same time, an interim payment of £30,000 was ordered while the final costs were determined (PJ, 29 May, p659). What was not known was the basis on which costs would be awarded.

In his final decision, issued last week, Mr Justice Park said that the claimants should pay the costs of all the defendants on the standard rather than on the more substantial indemnity basis. “There are aspects of the way in which the claim was made which I find unattractive but my final view is that they are not such that I ought to make an order for costs on the indemnity basis,” he stated.

He gives three reasons for opting for the standard basis. First, that Council members knew that the SOS group was contemplating legal proceedings if it decided to petition for a new Charter. Second, that he accepts that the SOS litigants were acting on legal advice when they decided to sue personally the 16 Council members who voted to petition for a new Charter, although in his view this was not necessary or appropriate. Finally, the fact that the 16 Council members were served with claim forms by post seemed reasonable. An earlier suggestion that they had been served with claim forms at their homes on Saturday morning had been shown to be untrue. Despite these points, Mr Justice Park commented that he was not convinced that the SOS action needed to be taken without trying a more conventional warning, such as a letter, first.

The SOS claimants have now been instructed to pay all the defendants’ costs, including the costs of the application for summary judgment.

The defendants have already produced an outline of their costs but will now have to produce a detailed breakdown that will be sent to the court and the SOS solicitors. It may be some months before an agreement is reached on the final sum. The Journal asked the Society what the costs were expected to be but the Society was unable to produce a figure at this stage.

Back to Top


©The Pharmaceutical Journal